Login / Signup
Correction: CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models.
Agnieszka K Witkiewicz
Derek Cox
Erik S Knudsen
Published in:
Genes & cancer (2021)
[This corrects the article DOI: 10.18632/genesandcancer.24.].
Keyphrases
</>
cell cycle
cell therapy
anti inflammatory
cell proliferation
bone marrow
childhood cancer